Other substances

Ginkgo biloba leaves extract

A plant extract.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Natural product

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Ginkgo biloba leaves extract was observed to inhibit SARS-CoV-2 3C-like protease (Xiong et al., 2021).

Ginkgo biloba on DrugBank
Ginkgo biloba on Wikipedia

 

Supporting references

Link Tested on Impact factor Notes Publication date
Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening
3CLpro Enzyme assay In vitro In silico 		in silico; in vitro enzyme assay 2.53

The extract inhibited SARS-CoV-2 3C-like protease with an IC50 of 6.68 μg/ml.

 Apr/22/2021
Export (.csv)